BioRay Pharmaceutical
Blood & Organ Banks · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Shugang Road 1 Jiaojiang District, Taizh...Phone Number
+86 2021020262Website
www.bioraypharm.comRevenue
<$5 MillionIndustry
About BioRay Pharmaceutical
BioRay Pharmaceutical Org Chart
Is BioRay Pharmaceutical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when BioRay Pharmaceutical launches new products
Congratulate Masked Content for being promoted to Masked Content at BioRay Pharmaceutical
Check out if BioRay Pharmaceutical is spiking on competitors!
Check if BioRay Pharmaceutical has recently received funding, and reach out quickly before it becomes old news!
BioRay Pharmaceutical, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if BioRay Pharmaceutical had a recent Job posting/layoffs
Funding: Get notified immidiatlly once BioRay Pharmaceutical has new funding data
Earning: See what the market has to say on BioRay Pharmaceutical recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at BioRay Pharmaceutical
Find more new buyers
Company Profile Activity
Activity Insights
BioRay Pharmaceutical is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
BioRay Pharmaceutical is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about BioRay Pharmaceutical.
BioRay Pharmaceutical Tech Stack
A closer look at the technologies used by BioRay Pharmaceutical
Top Blood & Organ Banks Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioRay Pharmaceutical
As a pioneer in China's biopharmaceutical industry, BioRay started the R&D of biologics treatments in 2019 as a core business division of Hisun Pharmaceutical, a specialty comprehensive pharmaceutical group founded in 1956. In 2019, PAG, a leading Asia-focused private equity firm, acquired the control of BioRay with an investment of RMB3.8B (USD$54... Read More